01Clinical rationale — case-for-referral
The single sentence that opens every referrer conversation.
"Unmanaged consumer debt in the last months of life is a clinical problem. It affects pain thresholds, family communication, treatment adherence, and the quality of the final weeks. Life Without Debt is the licensed referral pathway that resolves it — without adding to the household's burden, and without absorbing clinical time on financial casework."
Why this sentence works with clinical audiences
Three reasons. First, it names the problem as clinical, not social — which is how palliative-care clinicians already privately frame financial distress. Second, it draws a hard boundary: LWD does the financial work, the clinician does not. Third, it uses the word "licensed" — because a clinician's biggest fear when referring a household to a financial service is that the service is unlicensed, unregulated, or predatory. That fear is retired in the first breath.
The three clinical harms of unmanaged debt at end of life
These are the harms we cite when a clinician asks why this is a clinical problem, not a social work problem. Each is grounded in published evidence.
| Clinical harm | Mechanism | Published evidence base |
|---|---|---|
| Elevated pain scores and reduced treatment adherence | Financial distress raises baseline cortisol, sleep disruption, and non-adherence to prescribed opioid schedules. Household stress spillovers reach the patient within days. | Palliative-care service reports (PCA), Australian financial-hardship health-outcome studies. LWD cites, does not reinterpret. |
| Family communication breakdown in the final weeks | Undisclosed debt discovered post-mortem is the single most cited cause of long-term family estrangement in bereavement services casebooks. Pre-mortem resolution prevents this. | Bereavement services casebooks; Consumer Action Law Centre files on inherited debt disputes. |
| Delayed discharge and readmission risk | Households cannot accept discharge to home when home finances are collapsing. Palliative-care beds block; readmission rates rise. Debt resolution unlocks safe discharge. | Hospital social work case audit patterns; PHN system-integration reports. |
The clinical time argument (why referral saves clinical minutes)
The second-strongest argument for a clinical referrer is that LWD gives them clinical time back. Every case a social worker or palliative-care nurse spends triaging debt is a case they cannot spend on symptom management, family conferences, or discharge planning. LWD absorbs the financial casework end-to-end — from first phone call to final creditor letter — and returns only a written closure summary.
02The four-touchpoint referral pathway
The pathway is the product. Every referrer conversation ends at the pathway diagram. Memorise it — do not paraphrase it.
Referring clinician or hospital social worker completes a single-page referral form. Attaches clinical certification of terminal-illness status. Household consent captured on the form.
Clinical time cost: ≈ 90 seconds.
LWD advocate contacts the household within 24 hours of the referral landing. Full financial picture captured under the household's informed consent. Written acknowledgement returned to the referrer confirming intake — no clinical detail requested, no clinical time absorbed.
Referrer commitment: One inbox notification. No response required unless clinical status changes.
Creditor negotiation. Life-insurance activation. Hardship waivers. Aggregate mid-case update to the referrer at approximately day 12 — one paragraph, no confidential detail unless the household consents.
Referrer commitment: One inbox notification. No response required.
Written outcome summary to the referrer: total debt extinguished, inter-generational liability prevented, insurance activations completed. Case closed with signed household confirmation. Referrer credited in the annual audited impact report (subject to their consent).
Referrer commitment: File the closure letter in the household record. Done.
The three commitments the pathway makes to the clinical team
- We do not enter the clinical relationship. LWD advocates do not offer medical advice, do not review clinical decisions, and do not attempt to intervene in treatment. The clinical relationship remains the referrer's; the financial relationship becomes ours.
- We do not ask clinicians for follow-up work. The four touchpoints are the total clinical time investment for the case. Any clinician who receives a "please advise" email from LWD after intake should escalate it to the CMO as a process failure.
- We close the loop in writing. Every case ends with a closure letter to the referrer. No verbal-only outcomes. No email-only outcomes on hospital cases. The letter goes into the clinical file.
03Eligibility and scope discipline
Clinical trust is built on legible scope. Referrers stop referring to services whose acceptance criteria are unpredictable. Ours are deliberately narrow and written down.
LWD accepts referrals when:
- A household member has a specialist-certified terminal illness — typical life expectancy 24 months or less
- Consumer debt is present or likely (credit cards, personal loans, buy-now-pay-later, utility arrears, unpaid rent, medical debt)
- The household resides in Australia (any state or territory)
- The household has provided informed consent to the referral
- The referring party is a health-sector organisation, financial counsellor, community legal centre, or Aboriginal Community Controlled Health Organisation
LWD does not accept referrals when:
- Terminal-illness status is not clinically confirmed
- The debt is unrelated to a household member facing terminal illness
- The household has not consented to referral
- The presenting issue is business debt, tax debt not related to hardship, or fraud recovery
- The referral would compromise an existing legal proceeding without proper consent to intervene
Why the scope stays narrow
Every service that broadens its scope to please a referrer loses the referrer's trust within twelve months. Clinicians refer to services whose behaviour they can predict. Our narrow scope is a marketing asset, not a limitation — it is the reason a palliative-care nurse will reach for the LWD referral form in the diagnostic conversation instead of a general financial-counselling number.
Referring partner types accepted
- Public and private hospital palliative-care units
- Community and inpatient hospices
- Hospital social work departments
- State palliative-care networks
- Palliative Care Australia and its state members
- Condition-specific national charities (MND Australia, Cancer Council, Dementia Australia, MSK Australia, Prostate Cancer Foundation)
- Community health services and Primary Health Networks (PHNs)
- Aboriginal Community Controlled Health Organisations
- Financial counselling agencies (National Debt Helpline)
- Community legal centres
- Aged-care providers (residential and in-home)
- Specialist palliative-care clinicians and GPs
04Referrer talking points (for LWD-side conversations)
Six conversation cards. Written for the LWD Board member, CMO, or senior advocate meeting a clinician, hospital director, hospice CEO, or PHN executive. Every card is short enough to memorise before the meeting.
Q: What exactly does LWD do?
"We resolve consumer debt for households where a family member has a certified terminal illness. We take the referral, do all the financial casework — creditor negotiation, life-insurance activation, hardship waivers — and close the loop back to your team with a written outcome. Free to the household. Free to your organisation. Twenty-three days average cycle. We hold Australian Credit Licence 387398 through our related for-profit entity, and we operate under professional indemnity."
Q: How does this differ from a financial counsellor?
"Two differences that matter to a clinical team. First, we are cohort-specific — we only take terminal-illness households, which means our advocates know the diagnostic-window pressures your teams already know. Second, we close the loop in writing to the referrer. A general financial counsellor cannot do that at scale because the volume is too high. Our narrow cohort makes the closure discipline possible."
Q: What does an "average case" look like?
"Y1 data across thirty-one cases: $58,700 average total debt at intake; $1,840 average LWD cost per case; twenty-three days average to first substantive resolution; fifty-two percent average drop in psychological distress on the K10 scale from intake to closure. Eighty-seven cents of every dollar donated to LWD goes to direct service. Those numbers are audited annually and published."
Q: Who pays for it?
"Y1 through Y2, LWD is funded entirely by philanthropy — foundations, corporate partners, and regular giving from the public. From Y3, an optional embedded-advocate model becomes available for organisations that want a named LWD advocate stationed physically or virtually with their team. That's the only fee-for-service element. The core referral pathway remains free forever."
Q: What happens if the household has complex or business debt?
"We refer out. Our scope is consumer debt in the terminal cohort. If we open a case and discover material business debt or an active legal proceeding, we co-refer to the relevant specialist — community legal centre, Small Business Debt Helpline, or insolvency practitioner — and stay involved on the consumer portion only. The closure letter to your team names any co-referrals we made."
Q: What do you need from us to start?
"A signed MOU covering the referral flow, consent capture, data-handling under APP compliance, and the closure-letter format. Two to four weeks to sign. Ninety-day pilot on a low-volume ward or clinic, then expand across your network. We do the pilot design; you approve it. That's the total institutional cost of the partnership."
Phrase discipline for clinical audiences
Say:
- "Debt-hardship negotiation"
- "Household" or "family"
- "Referred household"
- "Written outcome to the referrer"
- "Terminal-illness cohort"
- "Clinical time cost"
- "Under Australian Credit Licence 387398"
- "Twenty-three-day average cycle"
Do not say:
- "Debt relief" (ASIC RG 96 outcome-language breach)
- "Patient" — the household is the referred party, not the patient (the patient remains the clinician's)
- "Client" — beneficiaries, not clients
- "Case management" — implies clinical case management, which we do not do
- "Financial counselling" — we are advocacy under an ACL, not counselling
- "Rescue" or "save" — reserved for clinical care, not financial work
- "We work with the doctor" — we do not enter the clinical relationship
05FAQ and objection handling — 10 clinical questions
The ten objections a clinical partner is most likely to raise. Every answer is designed to be delivered in under sixty seconds in a live meeting.
06MOU template outline
The referral MOU is the operational contract. Every clause below is standard across all referral partners; departures are exceptional and require Board approval.
| Clause | Purpose | Standard position |
|---|---|---|
| 01. Parties and purpose | Names the two organisations and defines the referral pathway as the sole scope of the MOU. | Referring organisation + Life Without Debt Ltd. Single-purpose MOU — no bundled clauses. |
| 02. Eligibility criteria | Locks the acceptance criteria from section 03 of this kit into the contract. | Verbatim reproduction of the "LWD accepts" and "LWD does not accept" lists. |
| 03. Referral form and consent | Defines the single-page form, mandatory fields, and household consent capture. | Signed household consent required at point of referral. No exceptions — including for emergency admissions. |
| 04. The four-touchpoint pathway | Contractually binds LWD to the pathway in section 02 of this kit. | 24-hour acknowledgement, mid-case update (aggregate), closure letter. All in writing. |
| 05. Data handling and Australian Privacy Principles | Data-processing schedule; retention periods; incident-notification protocol. | APP-compliant. Data retained for seven years post-closure under Australian Credit Licence record-keeping obligations, then destroyed. |
| 06. Safeguarding and escalation | Safe-call protocol, acute-distress escalation, clinician re-notification. | Annexed protocol reviewed by referring organisation's clinical governance lead pre-signing. |
| 07. Co-branding | Governs use of both parties' names and logos on referral materials and closure letters. | Co-branding permitted on forms, leaflets, closure letters. Advocacy delivered under LWD name and licence only. |
| 08. Impact reporting and referrer credit | Aggregate impact data returned to the referrer annually; naming credit in the audited impact report. | Annual anonymised data pack to referrer. Referrer named in the impact report subject to their consent. |
| 09. Term and review | Initial term, review cadence, termination. | Initial two-year term. Six-month review at day 180 of Y1. Terminable on 60 days' written notice by either party. |
| 10. Fees and financial obligations | Explicit "no fee to household, no fee to referring organisation" statement, with the Y3 embedded-advocate option carved out separately. | Free referral pathway for the initial term. Embedded-advocate fee-for-service optional from Y3 under a separate schedule. |
07Cultivation notes — PHA, MND Australia, condition charities, PHNs
Two founding partners are already in cultivation. Four other partner classes are the priority prospect pool. Notes below are for internal reference only — none of this is to be forwarded to prospects.
Palliative Care Australia (PCA) — founding partner in cultivation
Why: PCA is the peak national body for palliative care. A PCA-endorsed referral pathway becomes a de facto national standard across state palliative-care networks and the eight PHN palliative-care commissioning teams.
Cultivation status: Introductory conversations underway. Position Brief plus the four-touchpoint pathway diagram have been shared. MOU not yet issued.
Cultivation approach: Data-first. PCA leadership responds to cycle-time evidence and safeguarding rigour, not to case stories. Lead with the audited Y1 numbers, the APP-compliance framework, and the safe-call protocol. Story is reserved for the leaflet layer, not the executive layer.
What we need from PCA: Endorsement in principle, followed by a co-designed pilot with one to three state member organisations, followed by a national referral-pathway announcement in the PCA member communications channel.
MND Australia — founding partner in cultivation
Why: MND cases have exceptionally high consumer-debt loads at diagnosis — the disease trajectory forces rapid household-income collapse, and the average time from diagnosis to inability to work is under twelve months. The David composite in the Position Brief is drawn from this cohort ($8,400 LWD spend, 34 days to closure). MND Australia is a small, tightly-networked national charity that can move quickly.
Cultivation status: Introductory conversations underway. High receptivity in the leadership team.
Cultivation approach: Story + data. The MND cohort responds to both — leadership wants to see that we understand the specific disease trajectory (story) and that our numbers hold up in audit (data). Trust layer: our licensing and the safe-call protocol.
What we need from MND Australia: Referral pathway MOU covering their case-managers, plus co-marketing to their state member networks. Aim: 25 referrals in Y1 from MND Australia specifically.
Condition-specific national charities — priority prospect class
Cancer Council, Dementia Australia, Prostate Cancer Foundation, MSK Australia. These bodies operate national helplines and state member networks that are the natural upstream of terminal-illness referrals. Each has a different clinical culture — Cancer Council is highly cautious and evidence-led; Dementia Australia is deeply relational; MSK Australia is small and pragmatic. The cultivation cadence and materials should be tailored per prospect, but all four use the same MOU template.
Primary Health Networks (PHNs) — priority prospect class
Thirty-one PHNs across Australia, each commissioning primary care and community services in their catchment. PHNs are the strategic access point for scaling referral volume into general practice and community palliative-care services. The cultivation approach is population-health framing: "unmanaged terminal-illness household debt is a measurable driver of preventable hospital re-admission — we resolve it under licence, and we close the loop back to the clinician." Lead with PHN commissioning language.
Hospital palliative-care units — priority prospect class
Large public and private hospital palliative-care units with dedicated social work capacity. High referral volume potential but slower institutional decision-making — expect nine to eighteen months from first contact to signed MOU. Cultivation should be led by Carla (Board-facing) or Laurence (clinical-governance-facing), not by the CMO in isolation.
Hospice networks — priority prospect class
Community and inpatient hospice networks (state-level and national). Lower institutional velocity than hospitals but higher referral density per bed, and closer to the diagnostic window where LWD is most useful. Cultivation should emphasise the closure-letter discipline — hospice teams particularly value the written closure back to the file.
08Referrer nurture sequence — five touches, six weeks
The referrer nurture is deliberately slower than corporate or philanthropic nurtures. Clinical leaders are inbox-fatigued, so we send fewer emails and load each one with substance. Cadence: Day 0 · Day 10 · Day 24 · Day 38 · Week 6+.
Thank you and next steps
From: Lisa Hugo, Co-founder & Head of Philanthropy, Life Without Debt Ltd
Subject: Life Without Debt · following up on our conversation
Purpose: Ratify the discovery-meeting understanding in writing. Attach the four-touchpoint pathway diagram, the Y1 audited numbers one-pager, and the MOU outline. No ask beyond "let us know if the outline reads correctly to your team".
Length: ≈ 180 words plus attachments. Read time under 60 seconds.
Two questions we didn't get to
From: Carla Oliver (or CMO, depending on partner)
Subject: Two things from the LWD conversation that might help your governance discussion
Purpose: Address the two most common governance questions raised in discovery meetings: (1) how APP compliance and clinical data-handling interact, and (2) how the safe-call protocol works when a household is in acute distress. Both answered in writing so the referrer can circulate to their clinical governance lead.
Length: ≈ 220 words. Answers formatted for forwarding.
What a case actually looks like
From: Laurence Hugo, Advocate (ACL 387398)
Subject: A composite case, if it's useful for your team
Purpose: One composite (David — 48, Melbourne, MND, $8,400 LWD spend, 34 days to closure) narrated in clinical framing — what the intake conversation sounded like, what the creditor negotiation looked like, what went in the closure letter. Labelled "composite drawn from case-pattern data — not a real individual".
Length: ≈ 320 words. Written to be shareable at a clinical team meeting.
The referral MOU, if you're ready to look at it
From: Carla Oliver
Subject: Draft MOU attached for your legal team
Purpose: Formally issue the MOU. Note that legal turnaround is expected to take four to six weeks, and offer to attend a call with the partner's legal or clinical governance team to walk through any clauses.
Length: ≈ 140 words plus the MOU document. No further asks in the email.
Where things stand and one small thing
From: Carla Oliver
Subject: Quick check-in on LWD partnership progress
Purpose: Light-touch check-in every six weeks until MOU is signed or partner declines. Include one substantive update — a new data point from LWD's ongoing operation, a new partner announcement, or a piece of published clinical evidence relevant to their setting. Never send an empty "just checking in".
Length: ≈ 120 words. Positioned as a professional courtesy, not a sales chase.
09Stewardship playbook — closing the loop back to the clinician
Stewardship of a referral partner is the closure discipline, applied at the institutional level rather than the case level. Every closure letter is a stewardship touch; every quarterly report is a stewardship touch; every named credit in the impact report is a stewardship touch. Retain referral partners by closing loops.
| Touchpoint | Trigger | Owner | Format |
|---|---|---|---|
| Closure letter | Every case closure (≈ day 23 of the individual case) | Case advocate | Written summary, one page, filed in the household's clinical record. |
| Quarterly aggregate report | End of each quarter after first referral received | CMO | Anonymised data pack: case volume, cycle time, cohort breakdown, safeguarding escalations, safeguarding outcomes. |
| Semi-annual partner review | Six months and eighteen months post-MOU signing | Carla + CMO | In-person or video meeting with the partner's referral lead and clinical governance lead. Two-way — what is working, what needs adjustment. |
| Annual impact report credit | Publication of the annual audited impact report | Board via CMO | Named credit for the referring organisation (subject to their consent). Advance copy sent to the referrer's leadership team 14 days before public release. |
| Clinical governance review invitation | Annual, prior to MOU renewal | CMO | Written invitation to the partner's clinical governance lead to review LWD's safeguarding data, escalations, and process changes over the past year. |
| MOU renewal | 60 days before end of initial two-year term | Carla | Formal renewal letter with updated MOU (any changes redlined), plus a summary of the partnership's outcomes over the two-year term. |
Retention targets
MOU renewal at end of Y2 is the primary retention KPI for Room F. Y1 target: 100% renewal on the two founding partners (PCA and MND Australia) plus at least 60% renewal across the priority prospect class where MOUs were signed. Loss of a founding partner is a Board-level event and triggers a same-week post-mortem.
10Threading
Where this kit connects to the rest of the LWD ecosystem. Use these links in-meeting when a referrer asks "can I see how you talk to households directly?" or "can I read your governance documents?".
In-meeting talking prompts for the threading links
- If a referrer asks "what would our patients actually see?" → send them to how-lwd-can-help. Written at Flesch ≤ 8. Sentences ≤ 20 words. Zero jargon.
- If a referrer asks "how do we know this is safe and licensed?" → send them to room-f#trust. Every licence, every insurance policy, every governance role is named and linked to source.
- If a referrer asks "who else is doing this with you?" → send them to the seven-room hub. Explains how Room F fits into the wider fundraising and partnership portfolio, without asking them to donate.
- If a referrer asks "how do you know it works?" → send them to room-f#outcomes for the audited Y1 numbers, and offer to share the full impact report on request.